Male | Female | |||||
---|---|---|---|---|---|---|
<18 Years n=448,145 β* (95% CI) | 18-64 Years n=999,776 βa (95% CI) | > 65 Years n=251,642 βa (95% CI) | <18 Years n=413,708 βa (95% CI) | 18-64 Years n=1,207,273 βa (95% CI) | > 65 Years n=372,618 βa (95% CI) | |
HBOC testing | - | 0.20 (0.11, 0.29) P-value: <0.001 | 0.16 (-0.02, 0.34) P-value: 0.074 | - | 1.12 (0.43, 1.82) P-value: 0.004 | 0.22 (-0.34, 0.78) P-value: 0.411 |
Lynch syndrome testing | - | 0.16 (0.02, 0.31) P-value: 0.033 | 0.19 (-0.01, 0.39) P-value: 0.064 | - | 0.19 (-0.01, 0.38) P-value: 0.062 | 0.16 (0.07, 0.25) P-value: 0.003 |
Tier 2 molecular pathology proceduresb | 0.11 (-0.31, 0.54) P-value: 0.575 | -0.91 (-2.69, -0.87) P-value: 0.289 | 6.68 (0.38, 12.98) ivalue: 0.039 | 0.13 (-0.16, 0.41) P-value: 0.350 | -0.49 (-3.06, 2.08) P-value: 0.687 | 0.72 (-5.62, 7.06) P-value: 0.810 |
Any cancer genetic testingc | 0.11 (-0.34, 0.57) P-value: 0.606 | -0.06 (-1.86, 1.74) P-value: 0.946 | 7.35 (1.22, 13.47) P-value: 0.022 | 0.16 (-0.11, 0.42) P-value: 0.229 | 1.18 (-1.70, 4.07) P-value: 0.392 | 1.41 (-4.93, 7.76) P-value: 0.737 |